AlgiFilm™ proprietary oral film strips technology was developed by Biota utilizing alginates as major film forming polymers.
Alginates are generally recognized as safe (GRAS) polysaccharides extracted from brown marine macro-algae (seaweeds). Alginates form strong, flexible, transparent, odorless and tasteless films that upon placement in the oral cavity adhere strongly to oral mucosa and slowly dissolve by saliva.
AlgiFilm™ platform technology is covered by US Patent No. 8,840,935, titled “Orally Administrable Films and Preparations Thereof”.
PCT Application No. WO 2021/090309, titled “ORALLY ADMINISTRABLE FILMS COMPRISING POORLY WATER SOLUBLE ACTIVE INGREDIENTS AND PREPARATION THEREOF” cover alginate oral films comprising emulsified high-dosage hydrophobic bioactive ingredients.
Corresponding issued Japanese Patent 7664916, Indian Patent 567875, and European Patent 4054523, certify broad patent protection in three major markets.
Japan is the second-largest pharmaceutical market in the world, sustained by innovative industrial policy supporting high-value products.
Europe is the homeland of the modern pharmaceutical industry. European pharmaceutical companies are mature, competitive, and research-intensive.
The compelling advantages of AlgiFilm™ include:
- Discrete and easy administration at any time and any location
- Improved compliance, no choking hazard
- Pleasant tastes the evoke good feelings
- Optimized exact dosage
- Improved bioavialability
- Versatile technology
